MC

BPI 2026 · Consulting & services

Mill Creek Consulting at BPI 2026

Mill Creek Consulting brings 2 presentations to BPI 2026 in Boston. Its sessions cover investment in cell and gene therapies and phase-appropriate manufacturing. One looks at funding trends and opportunities for therapies and enabling technologies, and another argues for designing manufacturing with the end in mind.

OrganizationBPI 2026 Attendance
MC
Mill Creek Consulting
1 Principal
Panel
Wed Sep 23
2:40pm–3:20pm
Investor Panel Discussion: Funding the Future- Investment Trends and Opportunities for Cell and Gene Therapies and Enabling Technologies
Cell & Gene Keynote Plenary · with BroadOak Capital Partners, RA Capital Management, M Ventures +1 more
Talk
Thu Sep 24
4:30pm–5:30pm
Panel Discussion: Starting with the End in Mind: Designing Smart and Phase Appropriate Manufacturing for Successful Cell and Gene Therapy Development
Development of Emerging Cell & Gene Therapies · with Ultragenyx, Astellas Institute for Regenerative Medicine, Genetix Biotherapeutics

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Mill Creek Consulting

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction